Concepedia

Andrew J. Culshaw

AJ

11

Publications

822

Citations

11

H-Index

1992

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United Kingdom)

Novartis (Japan)

University of Oxford

Andrew J. Culshaw is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1992–2012

11

Publications

11

Direct Arylations of 2<i>H</i>-Indazoles On Water

Stephan A. Ohnmacht, Andrew J. Culshaw, Michael F. Greaney · Organic Letters · 2009 · 167 citations

Direct arylations on water: synthesis of 2,5-disubstituted oxazoles balsoxin and texaline

Stephan A. Ohnmacht, Patrizia Mamone, Andrew J. Culshaw et al. · Chemical Communications · 2008 · 155 citations

, , +12

Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone:  A Potent, Orally Bioavailable Human CB<sub>1</sub>/CB<sub>2</sub>Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration

Edward K. Dziadulewicz, Stuart Bevan, Christopher T. Brain et al. · Journal of Medicinal Chemistry · 2007 · 96 citations · Full text

Investigations into the Manzamine Alkaloid Biosynthetic Hypothesis

Jack E. Baldwin, Timothy D. W. Claridge, Andrew J. Culshaw et al. · Angewandte Chemie International Edition · 1998 · 96 citations

Studies on the Biomimetic Synthesis of the Manzamine Alkaloids

Jack E. Baldwin, Timothy D. W. Claridge, Andrew J. Culshaw et al. · Chemistry - A European Journal · 1999 · 96 citations

Rows per page

1–5 of 11